354 related articles for article (PubMed ID: 8292298)
1. Activation of dermal connective tissue in scleroderma.
Kähäri VM
Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue metabolism including cytokines in scleroderma.
Smith EA
Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of skin fibrosis in systemic sclerosis.
Jinnin M
J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
[TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
6. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
7. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
9. [Pathophysiology of fibroses. Progressive systemic scleroderma as a model disease].
Hein R; Mauch C; Braun-Falco O; Krieg T
Hautarzt; 1988 Feb; 39(2):65-71. PubMed ID: 3283077
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
11. Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet.
Lakos G; Melichian D; Wu M; Varga J
Pathobiology; 2006; 73(5):224-37. PubMed ID: 17314493
[TBL] [Abstract][Full Text] [Related]
12. What are the new milestones in the pathogenesis of systemic sclerosis?
Hunzelmann N; Brinckmann J
Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i52-56. PubMed ID: 19995745
[TBL] [Abstract][Full Text] [Related]
13. Immunological modulation of dermal fibroblasts in scleroderma.
Perlish JS; Fleischmajer R
Immunol Ser; 1989; 46():605-24. PubMed ID: 2488871
[TBL] [Abstract][Full Text] [Related]
14. The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma.
Ozbilgin MK; Inan S
Clin Rheumatol; 2003 Sep; 22(3):189-95. PubMed ID: 14505209
[TBL] [Abstract][Full Text] [Related]
15. Animal models of scleroderma: lessons from transgenic and knockout mice.
Derrett-Smith EC; Denton CP; Sonnylal S
Curr Opin Rheumatol; 2009 Nov; 21(6):630-5. PubMed ID: 19730378
[TBL] [Abstract][Full Text] [Related]
16. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
[TBL] [Abstract][Full Text] [Related]
17. Cytokine regulation of prolyl 4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: contribution to collagen synthesis and fibrosis.
Kawaguchi Y; Kitani A; Hara M; Harigai M; Hirose T; Suzuki K; Kawakami M; Hidaka T; Ishizuka T; Kawagoe M
J Rheumatol; 1992 Aug; 19(8):1195-201. PubMed ID: 1328634
[TBL] [Abstract][Full Text] [Related]
18. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
Ihn H; Yamane K; Kubo M; Tamaki K
Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
[TBL] [Abstract][Full Text] [Related]
19. TGF beta--a role in systemic sclerosis?
Cotton SA; Herrick AL; Jayson MI; Freemont AJ
J Pathol; 1998 Jan; 184(1):4-6. PubMed ID: 9582519
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
